Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRIAMCINOLONE Cause Psoriatic arthropathy? 342 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 342 reports of Psoriatic arthropathy have been filed in association with TRIAMCINOLONE. This represents 5.1% of all adverse event reports for TRIAMCINOLONE.

342
Reports of Psoriatic arthropathy with TRIAMCINOLONE
5.1%
of all TRIAMCINOLONE reports
164
Deaths
131
Hospitalizations

How Dangerous Is Psoriatic arthropathy From TRIAMCINOLONE?

Of the 342 reports, 164 (48.0%) resulted in death, 131 (38.3%) required hospitalization, and 105 (30.7%) were considered life-threatening.

Is Psoriatic arthropathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRIAMCINOLONE. However, 342 reports have been filed with the FAERS database.

What Other Side Effects Does TRIAMCINOLONE Cause?

Drug ineffective (3,035) Psoriasis (1,131) Off label use (901) Product use in unapproved indication (724) Condition aggravated (625) Therapeutic product effect incomplete (624) Treatment failure (612) Drug intolerance (527) Nausea (525) Pruritus (485)

What Other Drugs Cause Psoriatic arthropathy?

SECUKINUMAB (8,900) ADALIMUMAB (8,148) METHOTREXATE (7,167) APREMILAST (7,035) ETANERCEPT (6,518) CERTOLIZUMAB PEGOL (5,798) LEFLUNOMIDE (4,703) INFLIXIMAB (4,238) GOLIMUMAB (4,101) SULFASALAZINE (3,961)

Which TRIAMCINOLONE Alternatives Have Lower Psoriatic arthropathy Risk?

TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE TRIAMCINOLONE vs TRIAMTERENE TRIAMCINOLONE vs TRIATEC TRIAMCINOLONE vs TRIAZOLAM

Related Pages

TRIAMCINOLONE Full Profile All Psoriatic arthropathy Reports All Drugs Causing Psoriatic arthropathy TRIAMCINOLONE Demographics